Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities:    
Net (loss) income from continuing operations $ (1,055,265) $ 51,031
Adjustments to reconcile net (loss) income of continuing operations to net cash (used in) provided by operating activities of continuing operations    
Depreciation and amortization 80,425 25,617
Impairment of goodwill 1,092,714 0
Share-based compensation expense 5,187 5,796
Provision for revenue adjustments 2,159 2,812
Deferred income tax (benefit) expense (163,604) 2,182
Other 6,469 (1,733)
Changes in operating assets and liabilities, net of effects from the purchase of acquired businesses:    
Accounts receivable (42,265) 38,690
Other receivables 5,531 0
Other current and noncurrent assets (56,637) 10,609
Accounts payable and accrued expenses 28,362 (17,550)
Net cash (used in) provided by operating activities of continuing operations (96,924) 117,454
Investing activities:    
Proceeds from sale of property and equipment 1,406 3,171
Purchases of property and equipment (19,396) (16,836)
Purchase of a business, net of cash acquired (1,565,242) (56,703)
Other (174) 0
Net cash used in investing activities of continuing operations (1,583,406) (70,368)
Financing activities:    
Repayments of finance lease obligations (9,127) (3,923)
Proceeds from credit facility 0 45,000
Payments on credit facility (80,000) (30,750)
Payment of debt issuance costs (60,591) 0
Payment of earn-out liability (12,247) 0
Payments of dividends to shareholders 0 (12,600)
Repurchases and retirement of common stock 0 (79,792)
Proceeds from common stock issued under employee stock purchase plan 369 421
Payment of minimum tax withholdings on share-based awards (1,361) (4,292)
Contributions from subsidiary held for sale 0 11,309
Net cash used in financing activities of continuing operations (162,957) (74,627)
Effect of exchange rate changes on cash 745 0
Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents from continuing operations (1,842,542) (27,541)
Cash from discontinued operation:    
Net cash (used in) provided by operating activities of discontinued operation (4,876) 12,112
Net cash used in investing activities of discontinued operation 0 (739)
Net cash used in financing activities of discontinued operation 0 (11,373)
Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents (1,847,418) (27,541)
Cash, cash equivalents and restricted cash equivalents at beginning of period of continuing operations 1,952,073 45,822
Cash at beginning of period of discontinued operation 0 0
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period of continuing operations 104,655 18,281
Reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents:    
Cash and cash equivalents 84,886 18,281
Restricted cash and restricted cash equivalents 19,769 0
Total cash, cash equivalents, restricted cash and restricted cash equivalents shown in the statement of cash flow: 104,655 18,281
Non-Cash Transactions:    
Equipment acquired under finance leases $ 6,881 $ 14,994